These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29649374)

  • 61. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Harnessing massively parallel sequencing in personalized head and neck oncology.
    Jessri M; Farah CS
    J Dent Res; 2014 May; 93(5):437-44. PubMed ID: 24557572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gene therapy for head and neck cancers.
    Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
    Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy.
    Laban S; Giebel G; Klümper N; Schröck A; Doescher J; Spagnoli G; Thierauf J; Theodoraki MN; Remark R; Gnjatic S; Krupar R; Sikora AG; Litjens G; Grabe N; Kristiansen G; Bootz F; Schuler PJ; Brunner C; Brägelmann J; Hoffmann TK; Perner S
    Oncotarget; 2017 Feb; 8(9):14719-14735. PubMed ID: 28146422
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sequencing the head and neck cancer genome: implications for therapy.
    Sun W; Califano JA
    Ann N Y Acad Sci; 2014 Dec; 1333():33-42. PubMed ID: 25440877
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy.
    Horton JD; Knochelmann HM; Day TA; Paulos CM; Neskey DM
    Trends Cancer; 2019 Apr; 5(4):208-232. PubMed ID: 30961829
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunotherapy for Head and Neck Cancer.
    Sim F; Leidner R; Bell RB
    Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Head and neck cancer : promising results of immunotherapy].
    Sivade A; Bensaid D; Monnier Y; Shabafrouz K; Bouchaab H; Cristina V
    Rev Med Suisse; 2017 May; 13(563):1029-1031. PubMed ID: 28636292
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Precision medicine: In need of guidance and surveillance.
    Lin JZ; Long JY; Wang AQ; Zheng Y; Zhao HT
    World J Gastroenterol; 2017 Jul; 23(28):5045-5050. PubMed ID: 28811702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.
    Chau NG; Li YY; Jo VY; Rabinowits G; Lorch JH; Tishler RB; Margalit DN; Schoenfeld JD; Annino DJ; Goguen LA; Thomas T; Becker H; Haddad T; Krane JF; Lindeman NI; Shapiro GI; Haddad RI; Hammerman PS
    Clin Cancer Res; 2016 Jun; 22(12):2939-49. PubMed ID: 26763254
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immuno-oncology in head and neck squamous cell cancers: News from clinical trials, emerging predictive factors and unmet needs.
    Cavalieri S; Rivoltini L; Bergamini C; Locati LD; Licitra L; Bossi P
    Cancer Treat Rev; 2018 Apr; 65():78-86. PubMed ID: 29574334
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunotherapy for head and neck squamous cell carcinoma.
    Li Q; Prince ME; Moyer JS
    Oral Oncol; 2015 Apr; 51(4):299-304. PubMed ID: 25624094
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Precision medicine for advanced prostate cancer.
    Mullane SA; Van Allen EM
    Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D; Duan L; Freimuth P; O'Malley BW
    Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunotherapy for head and neck cancer: the future of treatment?
    Xie X; O'Neill W; Pan Q
    Expert Opin Biol Ther; 2017 Jun; 17(6):701-708. PubMed ID: 28368668
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
    Bauman JE; Cohen E; Ferris RL; Adelstein DJ; Brizel DM; Ridge JA; O'Sullivan B; Burtness BA; Butterfield LH; Carson WE; Disis ML; Fox BA; Gajewski TF; Gillison ML; Hodge JW; Le QT; Raben D; Strome SE; Lynn J; Malik S
    Cancer; 2017 Apr; 123(7):1259-1271. PubMed ID: 27906454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Precision Medicine: Genomic Profiles to Individualize Therapy.
    Streeter OE; Beron PJ; Iyer PN
    Otolaryngol Clin North Am; 2017 Aug; 50(4):765-773. PubMed ID: 28527522
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.
    Bryan RB; Gough MJ; Seung SK; Jutric Z; Weinberg AD; Fox BA; Crittenden MR; Leidner RS; Curti B
    Oral Oncol; 2016 Oct; 61():166-76. PubMed ID: 27614589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.